New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage ...
FORT MYERS, Fla., Jan. 8, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) advances gastrointestinal cancer treatment through participation at the global ASCO (R) 2025 ...
LUND, SE / ACCESS Newswire / January 9, 2026 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showcasing ...
Please provide your email address to receive an email when new articles are posted on . In 2020, the global lifetime risk for developing and dying from gastrointestinal cancers was 8.2% and 6.17%.
MedPage Today on MSN
JFK's Granddaughter Dies From AML; GI Cancers Expected to Double; Cancer Trials Axed
Tatiana Schlossberg, daughter of Caroline Kennedy and granddaughter of President John F. Kennedy, died from acute myeloid ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果